Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III study.
Sedik S, Egger M, Wolfgruber S, Salmanton-García J, Bassetti M, Mikulska M, Özenci V, Arikan-Akdagli S, Akova M, Gangneux JP, Bandera A, Alastruey-Izquierdo A, Barac A, Rautemaa-Richardson R, de Jonge NA, Loughlin L, Blennow O, Lanternier F, Meijer EFJ, Khanna N, Garcia-Vidal C, Dávila-Valls J, Klimko N, Khostelidi SN, White PL, Akalin H, Rogers B, Ruiz M, García-Rodríguez J, Akyol D, Longval T, Danion F, Prattes J, Krause R, Biswas SK, Arendrup MC, Koehler P, Cornely OA, Hoenigl M; ECMM Candida III study group.
Sedik S, et al. Among authors: biswas sk.
J Infect. 2025 Nov;91(5):106629. doi: 10.1016/j.jinf.2025.106629. Epub 2025 Oct 15.
J Infect. 2025.
PMID: 41106444
Free article.